Safety, Immunogenicity and Efficacy of the Blood-stage Plasmodium Vivax Malaria Vaccine Candidate PvDBPII in Matrix M1
NCT04201431
·
clinicaltrials.gov ↗
PHASE1,PHASE2
Phase
COMPLETED
Status
24
Enrollment
OTHER
Sponsor class
Conditions
Malaria, Vivax
Interventions
BIOLOGICAL:
PvDBPII/Matrix-M1
Sponsor
University of Oxford